CYTOKINETICS INC (CYTK) Stock Income Statement
NASDAQ:CYTK - Nasdaq - US23282W6057 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.22M | 18.47M | 7.53M | 94.60M | 70.40M | |||
| Operating Expenses | 584.86M | 554.72M | 503.74M | 418.80M | 256.70M | |||
| Research and Development | 357.68M | 339.41M | 330.12M | 240.80M | 159.90M | |||
| Selling, General, and Administrative Expenses | 227.18M | 215.31M | 173.61M | 178.00M | 96.80M | |||
| Operating Income | -565.64M | -536.25M | -496.20M | -324.20M | -186.30M | |||
| Interest Income/Expense | -33.91M | -33.68M | -30.04M | -39.80M | -29.00M | |||
| Other Income/Expense | -15.70M | -19.60M | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | 0.00 | 0.00 | -24.90M | N/A | |||
| Income Before Taxes | -615.26M | -589.53M | -526.24M | -389.00M | -215.30M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -615.26M | -589.53M | -526.24M | -389.00M | -215.30M | |||
| EBITDA | -556.14M | -526.72M | -484.31M | -318.39M | -184.02M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.31 | -5.26 | -5.45 | -4.33 | -2.80 | |||
| Non GAAP EPS | -5.32 | -5.26 | -5.45 | -4.22 | -2.83 | |||
| Statistics | ||||||||
| Profit Margin | -3201.47% | -3191.11% | -6988.63% | -411.21% | -305.82% | |||
| Operating Profit Margin | -2943.30% | -2902.72% | -6589.71% | -342.71% | -264.63% | |||
All data in USD